BRAF and central nervous system cancer: Mutation hotspots such as BRAFV600, IDH1R132, IDH2R172, and IDH2R140 are prime examples where identifying mutational status during surgery could inform more-aggressive resection (BRAF mutant) or less-aggressive resection (IDH1/2 mutant) of gliomas.